ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

Clinical trial NCT04205227 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04205227
Sponsor: ENB Therapeutics, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Melanoma Ovary Cancer Pancreatic Cancer Solid Tumor

Start date: 2020-02-18
Primary completion: 2026-01-01
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.